XML 54 R40.htm IDEA: XBRL DOCUMENT
v3.8.0.1

ORGANIZATION AND BASIS OF PRESENTATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Subsidiaries |
Entities |  | Date of establishment/acquisition |  | Place of establishment |  | Percentage of ownership by the Company |  | Principal activities |
Subsidiaries |  |  |  |  |  |  |  |  |
Ascendium Group Limited (“Ascendium”) |  | September 10, 2007 |  | British Virgin Islands (“BVI”) |  | 100 | % | Investment holding |
Our Medical Services Limited (“OMS”) |  | August 22, 1996 |  | BVI |  | 100 | % | Investment holding |
Medstar Oversea Ltd. (“Medstar Overseas”) |  | September 22, 2011 |  | BVI |  | 100 | % | Investment holding |
Cyber Medical Networks Limited (“Cyber”) |  | May 26, 2006 |  | Hong Kong |  | 100 | % | Investment holding |
China Medical Services (Holdings) Limited (“CMS Holdings”) |  | July 18, 2008 |  | Hong Kong |  | 100 | % | Investment holding |
King Cheers Holdings Limited (“King Cheers”) |  | May 18, 2001 |  | Hong Kong |  | 100 | % | Investment holding |
Shenzhen Aohua Medical Technology and Services Co., Ltd. (“Aohua Technology ”) |  | February 21, 2008 |  | PRC |  | 100 | % | Leasing of medical equipment and provision of management services |
Medstar (Shanghai) Leasing Co., Ltd. (“Shanghai Medstar”) |  | March 21, 2003 |  | PRC |  | 99 | % | Leasing of medical equipment and provision of management services |
Beijing MeizhongJiahe Hospital Management Co., Ltd.(“MHM”)* |  | July 23, 2008 |  | PRC |  | 85.34 | % | Provision of management services |
Beijing Yundu Internet Technology Co., Ltd. (“Yundu”) |  | July 26, 2007 |  | PRC |  | 100 | % | Provision of management services |
Tianjin Concord Medical Technology Limited(“Tianjin Concord Medical”) |  | April 22, 2010 |  | PRC |  | 100 | % | Leasing of medical equipment and provision of management services |
Guangzhou Jinkangshenyou Investment Co., Ltd. (“JKSY”) |  | August 12, 2010 |  | PRC |  | 100 | % | Leasing of medical equipment |
Guangzhou Concord Medical Cancer Hospital Co., Ltd. (“Guangzhou Concord Cancer Hospital”) |  | June 29, 2011 |  | PRC |  | 70 | % | Medical technology research and development, and provision of management and consulting services. |
CCM (Hong Kong) Medical Investments Limited (“CCM (HK)”)** |  | June 03, 2013 |  | Hong Kong |  | 85.71 | % | Investment holding |
CMS Radiotherapy Holdings Limited (“CMS (USA)”) |  | August 13, 2013 |  | United States of America |  | 100 | % | Investment holding |
Shenzhen Concord Medical Investment Limited (“SZ CMS”) |  | January 10, 2014 |  | PRC |  | 100 | % | Investment holding |
Shanghai Concord Oncology Hospital Limited (“SHC”) |  | March 17, 2014 |  | PRC |  | 90 | % | Group’s medical treatment and service business |
Global Medical Imaging (HongKong) Limited. (“GMI”) |  | May 26, 2014 |  | Hong Kong |  | 100 | % | Investment holding |
Datong MeizhongJiahe Cancer Center (“DTMZ”) |  | October 23, 2014 |  | PRC |  | 100 | % | Group’s medical treatment and service business |
Wuxi Concord Medical Development Ltd.("Wuxi Concord”) |  | December 29, 2015 |  | PRC |  | 100 | % | Group’s medical treatment and service business |
Concord Hospital Management Group Ltd.(HK) (“CHMG”) |  | July 7, 2015 |  | Hong Kong |  | 100 | % | Group’s medical treatment and service business |
Beijing Concord Medical Technology Ltd. |  | January 4, 2016 |  | PRC |  | 100 | % | Provision of management services |
Taizhou Concord Leasing Ltd. |  | April 20, 2016 |  | PRC |  | 100 | % | Group’s medical treatment and service business |
VIE |  |  |  |  |  |  |  |  |
Zhongrong Internation Growth Fund SPC-ZR ConcordHealthcare Investment Fund SP (“SP”) |  | November 2016 |  | Cayman Islands |  | 25 | % | Investment holding |
Subsidiaries of VIE |  |  |  |  |  |  |  |  |
US Proton Therapy Holdings Limited (“Proton BVI”) |  | May 16, 2011 |  | BVI |  | 100 | % | Investment holding |
US Proton Therapy Holdings Limited (“US Proton”) |  | June 29, 2011 |  | United States of America |  | 100 | % | Investment holding |
Concord Medical Services (International) Pte. Ltd. (“China Medstar”) (formerly known as China Medstar Pte. Limited) |  | August 8, 2003 |  | Singapore |  | 100 | % | Investment holding |
Concord Healthcare Singapore Pte. Ltd. (“CHS”) |  | April1, 2015 |  | Singapore |  | 100 | % | Group’s medical treatment and service business |
* On August 27, 2015, the Group changed the name of CMS Hospital Management Co., Ltd. (“CHM”) to Beijing MeizhongJiahe Hospital Management Co., Ltd. (“MHM”), providing management service to the Group’s existing network. On September 29, 2016, MHM completed its first round private offering of additional 926,000 ordinary shares to five institutional investors with a consideration of RMB41,670 (US$ 6,002), among which one investor thereafter transferred all the shares acquired back to the Group in the secondary market. In November 2016, the Group transferred 1,483,000 ordinary shares to and bought 10,000 ordinary shares from other existing shareholders in the secondary market. On December 30, 2016, MHM completed its second round private offering of additional 6,666,666 ordinary shares to two new institutional investors with a consideration of RMB100,000 (US$ 14,403). After the completion of all transactions mentioned above, the Group ultimately holds 85.34% equity interest in MHM. ** On September 9, 2015, CCM (HK) issued (i) 61,302,441 shares to Gopher CCM limited (“Gopher”), an entity controlled by a director of the Company, for a consideration of US$7,859 and (ii) 366,685,949 shares to Ascendium for a consideration of US$47,011, among which US$40,728 has been injected in 2015. As a result, Gopher holds 14.29% equity interest of CCM (HK) and through which, Gopher indirectly holds 10% of SHC, which is 70% owned by CCM (HK) and Ascendium holds 85.71% equity interest of CCM (HK).
Schedule of financial information |
|  |  |  | As at December 31, |
|  |  |  | 2017 |  | 2017 |
|  |  |  | RMB |  | US$ |
ASSETS |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash |  |  |  |  | 13,161 |  |  | 2,023 |
Restricted cash, current portion |  |  |  |  | 42 |  |  | 6 |
Accounts receivable (net of allowance of RMB73 (US$11) as of December 31, 2017) |  |  |  |  | 3,985 |  |  | 612 |
Inventories |  |  |  |  | 1,399 |  |  | 215 |
Prepayments and other current assets |  |  |  |  | 1,988 |  |  | 306 |
Total current assets |  |  |  |  | 20,575 |  |  | 3,162 |
Non-current assets: |  |  |  |  |  |  |  |  |
Property, plant and equipment, net |  |  |  |  | 279,240 |  |  | 42,918 |
Intangible assets, net |  |  |  |  | 202 |  |  | 31 |
Deposits for non-current assets |  |  |  |  | 172 |  |  | 26 |
Equity method investments |  |  |  |  | 195,040 |  |  | 29,977 |
Other non-current assets |  |  |  |  | 481 |  |  | 74 |
Total non-current assets |  |  |  |  | 475,135 |  |  | 73,026 |
Total assets |  |  |  |  | 495,710 |  |  | 76,188 |
|  |  |  | As at December 31, |
|  |  |  | 2017 |  | 2017 |
|  |  |  | RMB |  | US$ |
Current liabilities: |  |  |  |  |  |  |  |  |
Accounts payable |  |  |  |  | 1,978 |  |  | 304 |
Accrued expenses and other liabilities |  |  |  |  | 21,321 |  |  | 3,277 |
Amount due to inter-companies* |  |  |  |  | 54,563 |  |  | 8,386 |
Total current liabilities |  |  |  |  | 77,862 |  |  | 11,967 |
Non-current liabilities: |  |  |  |  |  |  |  |  |
Deferred tax liabilities |  |  |  |  | 8,316 |  |  | 1,278 |
Mandatorily redeemable noncontrolling interests |  |  |  |  | 396,281 |  |  | 60,907 |
Total non-current liabilities |  |  |  |  | 404,597 |  |  | 62,185 |
Total liabilities |  |  |  |  | 482,459 |  |  | 74,152 |
* Amount due to inter-companies represented payable balances of VIE and its subsidiaries due to other subsidiaries within the Group.
|  |  |  | As at December 31, |
|  |  |  | 2017 |  | 2017 |
|  |  |  | RMB |  | US$ |
Net revenues |  |  |  |  | 28,673 |  |  | 4,407 |
Net loss |  |  |  |  | (141,188) |  |  | (21,700) |
|  |  |  | As at December 31, |
|  |  |  | 2017 |  | 2017 |
|  |  |  | RMB |  | US$ |
Net cash used in operating activities |  |  |  |  | (54,113) |  |  | (8,317) |
Net cash used in investing activities |  |  |  |  | (5,582) |  |  | (858) |
Net cash generated from financing activities |  |  |  |  | 56,787 |  |  | 8,728 |
Exchange rate effect on cash, net |  |  |  |  | 748 |  |  | 115 |
Decrease in cash and cash equivalents |  |  |  |  | (2,160) |  |  | (332) |

X
- Definition Schedule Of Subsidiaries And Principal Activities [Table Text Block] + References No definition available. + Details
Name: | ccm_ScheduleOfSubsidiariesAndPrincipalActivitiesTableTextBlock
Namespace Prefix: | ccm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=77990344&loc=d3e5747-111685 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=77990344&loc=SL6228884-111685 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=77990344&loc=d3e5728-111685 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -URI http://asc.fasb.org/extlink&oid=77990344&loc=SL6759159-111685 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=77990344&loc=d3e5710-111685 + Details
Name: | us-gaap_ScheduleOfVariableInterestEntitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration